BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center For Technology Licensing
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260429T120000
DTEND;TZID=America/New_York:20260429T130000
DTSTAMP:20260611T060341
CREATED:20260315T161851Z
LAST-MODIFIED:20260402T204915Z
UID:10000594-1777464000-1777467600@ctl.cornell.edu
SUMMARY:Lab to Impact: The Rocky Road to Instant Ice Cream
DESCRIPTION:Join us for a discussion on the journey from scientific breakthrough to commercial success in food technology. \nUsing the evolution of instant ice cream as a case study\, this session explores what it takes to move from lab innovation to a product people trust\, adopt\, and buy. \nOur speakers—spanning academia\, entrepreneurship\, and industry—will share firsthand perspectives on navigating regulatory requirements\, scaling production\, and building a viable business around novel food technologies. \nWe’ll cover:\n• Bridging research and commercial viability\n• Navigating food safety regulations\n• Scaling production while maintaining quality\n• Building consumer trust\n• Securing investment and partnerships \nSpeakers: Syed Ruzvi\, professor at Cornell CALS\, and Aris Despo\, seasoned tech entrepreneur. Hosted by Marie Donnelly\, Business Development and Licensing Manager at CTL. \nRegister here. 
URL:https://ctl.cornell.edu/event/lab-to-impact-the-rocky-road-to-instant-ice-cream
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/09/CTL_CommVenture_icon2-e1770768070564.png
LOCATION:https://ctl.cornell.edu/event/lab-to-impact-the-rocky-road-to-instant-ice-cream
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260506T120000
DTEND;TZID=America/New_York:20260506T130000
DTSTAMP:20260611T060341
CREATED:20260315T162222Z
LAST-MODIFIED:20260407T180804Z
UID:10000595-1778068800-1778072400@ctl.cornell.edu
SUMMARY:Lab to Impact: The Hard Reality of Building a Biotech Startup - A CEO's Perspective
DESCRIPTION:What does it take to build a biotechnology company that advances early academic assets into a therapy used at the bedside\, while overcoming the scientific\, clinical\, and financial hurdles along the way? \nIn this session\, Laurence Blumberg\, MD\, MBA\, a physician and serial biotech entrepreneur\, shares a candid perspective drawn from decades of experience founding biotechnology companies and advancing scientific discoveries into clinical development. As founding CEO of Syntimmune\, he guided the company through early clinical development before its acquisition by Alexion in 2018 for up to $1.2 billion. Earlier\, he co-founded Syntonix Pharmaceuticals\, where his early strategic vision helped shape a protein engineering platform later acquired by Biogen in 2007. That platform ultimately enabled the development of Eloctate and Alprolix\, long-acting therapies for hemophilia A and B that have significantly improved care for patients with bleeding disorders. \nThis conversation examines the operational and strategic realities of building a therapeutics company. Topics will include: \n\nUnderstanding the structure of the biotechnology ecosystem\nDeveloping a rigorous Target Product Profile and market thesis\nDeciding when to build internal capabilities versus leveraging external partners such as CROs and CDMOs\nSecuring the capital and strategic partnerships required to advance therapies through development\n\nResearchers\, physicians\, and aspiring bioentrepreneurs are invited to join this candid conversation. \nHosted by Lynda Inseque\, director of Technology & Venture Initiatives and Engagement at CTL. \nRegister here. 
URL:https://ctl.cornell.edu/event/lab-to-impact-the-hard-reality-of-building-a-biotech-startup-a-ceos-perspective
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/09/CTL_CommVenture_icon2-e1770768070564.png
LOCATION:https://ctl.cornell.edu/event/lab-to-impact-the-hard-reality-of-building-a-biotech-startup-a-ceos-perspective
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260520T113000
DTEND;TZID=America/New_York:20260520T134500
DTSTAMP:20260611T060341
CREATED:20260511T232249Z
LAST-MODIFIED:20260511T232341Z
UID:10000601-1779276600-1779284700@ctl.cornell.edu
SUMMARY:Bearers of Innovation 2026
DESCRIPTION:Bearers of Innovation: A One Cornell Celebration is an annual\, invitation-only celebration recognizing Cornell researchers and inventors who took a meaningful step forward in the technology commercialization journey — whether by disclosing a technology for the first time or reaching a licensing milestone. \nThis year’s celebration honors inventors from FY2024 and FY2025 across Cornell’s Ithaca and New York City campuses\, bringing together the broader Cornell innovation community to recognize the work that moves discoveries from the lab toward real-world impact. \nAttendance is by invitation only. Invitations are extended directly to recognized inventors by CTL leadership and the Business Development and Licensing team.
URL:https://ctl.cornell.edu/event/bearers-of-innovation-2026
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/04/BOI-Final-logo_square-e1778541808230.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260618T120000
DTEND;TZID=America/New_York:20260618T130000
DTSTAMP:20260611T060341
CREATED:20260603T210029Z
LAST-MODIFIED:20260603T210029Z
UID:10000602-1781784000-1781787600@ctl.cornell.edu
SUMMARY:Lab to Impact: Customer Discovery in Early-Stage Life Sciences
DESCRIPTION:Most life science companies don’t fail because the science was wrong. They fail because no one validated the problem\, the customer\, or the market before spending years — and millions — building toward them. \nJoin the Center for Technology Licensing (CTL) for Customer Discovery in Early-Stage Life Sciences\, a virtual conversation for researchers\, faculty innovators\, and aspiring founders working at the edge of translation. Attendees will learn how experienced practitioners approach customer discovery in regulated\, technically complex life science markets\, and how that work shapes everything from product design to capital strategy. \nThe panel features: \n\nAudrey Beckman\, Partner and Chief Innovation Officer at Boomerang Ventures\, who evaluates and co-builds health tech companies\nDave Saunders\, Product Development Advisor at AiM Medical Robotics\, whose MRI-guided neurosurgery robot has just completed first-in-human trials\nDr. Amir Goldan\, Associate Professor at Weill Cornell Medicine and serial inventor of Prism-PET and NeuroTwain\, who is currently navigating the leap from lab to market.\nThe discussion will be moderated by Donna Rounds\, Ph.D.\, from CTL at Weill Cornell.\n\nRegister here. 
URL:https://ctl.cornell.edu/event/lab-to-impact-customer-discovery-in-early-stage-life-sciences
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/09/CTL_CommVenture_icon2-e1770768070564.png
LOCATION:https://ctl.cornell.edu/event/lab-to-impact-customer-discovery-in-early-stage-life-sciences
END:VEVENT
END:VCALENDAR